The Journal of Allergy and Clinical Immunology
Volume 123, Issue 6 , Pages 1335-1341 , June 2009

Adolescents and asthma: Why bother with our meds?

  • David R. Naimi, DO

      Affiliations

    • Division of Allergy and Immunology, the Children's Hospital of Philadelphia, Philadelphia, Pa
    • ,
  • Tovia G. Freedman, DSW, LCSW

      Affiliations

    • Clinical and Research Consultant, Philadelphia, Pa
    • ,
  • Kenneth R. Ginsburg, MD, MS Ed

      Affiliations

    • Division of Adolescent Medicine, the Children's Hospital of Philadelphia, Philadelphia, Pa
    • ,
  • Daniel Bogen, MD, PhD

      Affiliations

    • Department of Bioengineering, University of Pennsylvania, Philadelphia, Pa
    • ,
  • Cynthia S. Rand, PhD

      Affiliations

    • Pulmonary and Critical Care Medicine, the Johns Hopkins School of Medicine, Baltimore, Md
    • ,
  • Andrea J. Apter, MD, MSc

      Affiliations

    • Section of Allergy and Immunology, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania, Philadelphia, Pa
    • Corresponding Author InformationReprint requests: Andrea J. Apter, MD, MSc, 829 Gates Building, Hospital of the University of Pennsylvania, 3600 Spruce St, Philadelphia, PA 19104.

Received 2 January 2009 ,Revised 3 February 2009 ,Accepted 3 February 2009.

  • Image Result

    Frequency distribution of mean truncated adherence. Adherence is expressed as the mean of adherence of the monitoring periods as a percentage adherence truncated at 100%.

    Frequency distribution of mean truncated adherence. Adherence is expressed as the mean of adherence of the monitoring periods as a percentage adherence truncated at 100%.

 D. R. Naimi is supported by the American Academy of Allergy, Asthma & Immunology Sepracor Research Excellence Award and A. J. Apter is supported by grants HL070392 and HL088469.

 Disclosure of potential conflict of interest: D. R. Naimi received the American Academy of Allergy, Asthma & Immunology Sepracor Research Excellence Award. D. Bogen received grant support from the National Institutes of Health. C. S. Rand is on the advisory board for the Merck Foundation/HCAN and on the leadership council for Schering-Plough. A. J. Apter received grant support from the National Institutes of Health/National Heart Lung Blood Institute. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)00345-5

doi: 10.1016/j.jaci.2009.02.022

The Journal of Allergy and Clinical Immunology
Volume 123, Issue 6 , Pages 1335-1341 , June 2009

Article Tools

* Image Usage & Resolution